RvD1 disrupts nociceptor neuron and macrophage activation and neuroimmune communication- reducing pain and inflammation in gouty arthritis in mice
Envoyer une demande de publication
close

Demande de publication

Merci pour votre intérêt pour nos produits et votre demande concernant cette publication, qui vous sera envoyée si le chercheur et le journal l'autorisent. Notre équipe commerciale vous contactera rapidement.



- Catégories : Arthrite & Arthrose , Publications - ID: 1547

Authors
TH Zaninelli, V Fattori, T Saraiva‐SantoS


Lab
Universidade Estadual de Londrina, Londrina, ParanA, Brazil

Journal
British Journal of Pharmacology

Abstract
Gouty arthritis is characterized by an intense inflammatory response to monosodium urate crystals (MSU), which induces severe pain. Current therapies are often ineffective in reducing gout-related pain. Resolvin D1 (RvD1) is a specialized pro-resolving lipid mediator with anti-inflammatory and analgesic proprieties. In this study, we evaluated the effects and mechanisms of action of RvD1 in an experimental mouse model of gouty arthritis, an aim that was not pursued previously in the literature.

BIOSEB Instruments Used:
Electronic Von Frey 4 (BIO-EVF4),Electronic Von Frey 5 with embedded camera (BIO-EVF5)

Partager ce contenu